Thrive Without Compromise. Next Generation
Drug-Eluting Biomaterials.
At Elutia, we are pioneering the future of patient care. Our proprietary drug-eluting biomaterial platform stands at the forefront of medical innovation. We are dedicated to solving the persistent challenges of traditional medical implants by integrating drugs, biologics and advanced science. Our focus is on creating solutions that improve patient outcomes, helping every patient not only recover but truly thrive.
Thrive Without Compromise. Next Generation
Drug-Eluting Biomaterials.
Our Mission
Humanizing medicine so patients can thrive without compromise.
“Our mission is to make medicine work in harmony with the body. Our proprietary drug-eluting biomaterial technology is designed to unlock the full therapeutic potential of implants used in reconstruction procedures. By addressing the leading causes of post-surgical complications, we’re redefining expectations for patients and physicians alike.”
C. Randal Mills, PhD.
Founder, President, and CEO, Elutia
Bridging the Gap:
Drugs, Devices, and Biomatrices.
Elutia’s proprietary drug-eluting biologic technology fuses biologic material with extended antibiotic release, optimized for device implantation and soft tissue reconstruction.
Built on our high-performance biologic matrices—the foundation of regenerative medicine— our portfolio enables surgeons to perform complex reconstructive procedures using natural, regenerative materials.
Reconstruction
High-performance allograft for soft tissue reconstruction and natural remodeling.
Cardiovascular
complex surgical repair and natural healing.
Elutia Digital Education
Want to Receive Updates About Upcoming Webinars?
Join us for our free digital education series. Click the button below and sign up today for access to our next webinar.
1. Data on file at Elutia Inc.
WMK-1502-01D